Genelabs's Q3 loss shrinks as revenue more than doubles
13th Nov 2006, 16:11 GMT
Genelabs Technologies Inc. on Monday reported third quarter loss of $600,000, or 3 cents a share, down from a year-ago loss of $2.8 million, or 16 cents a share.
Genelabs's Q3 loss shrinks as revenue more than doubles related news:
- Genelabs reports lower Q3 loss — Latest news from San Francisco Business Times
- Genelabs Technologies Reports Financial Results for Q3 and 1st 9 Months of 2006 — Partnerships/ Joint Ventures News from StratCenter.com
- Viscount Systems Inc.: Viscount Reports Q3 2006 Results — Market Wire - Telecom
- Solexa Narrows 3Q Loss — Bio-Technology News from StratCenter.com
- Iomai 3Q Loss Widens — StratWire - Business of Healthcare NewsFeed
- eGene Reports a Profitable Quarter Result and Revenue Increases 273% in Q3 2006 Compared to Q3 2005 — Operations-Related News from StratCenter.com
- Akeena Solar posts Q3 loss despite higher revenue — Latest news from Silicon Valley/San Jose Business Journal
- Quarterly loss, revenue increase for ICOP — Latest news from Kansas City Business Journal
- CHAD Therapeutics revenue down, loss up in 2Q — Latest news from Los Angeles Business from bizjournals
- Fatter revenue helps Smart Online trim loss — Latest news from Triangle Business Journal
Latest news from Latest news from Silicon Valley/San Jose Business Journal:
- Pulte pulls out Extreme Networks HQ purchase
- San Jose's A10 gets $9M in new funding
- Micrus narrows Q2 loss on 137% revenue jump
- Sun opens source code for Java
- Illumina to buy Solexa for about $600M
- Accuray plans to raise up to $230M in IPO
- SumTotal Systems buys Mindsolve Technologies for $12M
- New funding for Web facilitator of government tech sales
- Sony signs N. First Street lease, apartments coming to former campus
- Economist Milton Friedman dead at 94